Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche buys antibody engineering firm led by ex-Serono team

This article was originally published in Scrip

Executive Summary

Roche is to pay $133.75m up front and up to $355m in additional milestone-dependent payments to acquire a bispecific antibody company set up by former managers from Merck Serono. Privately owned Dutalys of Austria has developed a novel class of fully human monoclonal antibodies called DutaMabs, designed to bind two antigens with high affinity and specificity.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC027293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel